Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Similar documents
Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

General Characterisctics

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent)

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

3 Ruba hussein Dr. ahmad Dr. ahmad

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration

Blood Cell Identification Graded

HAEMOLYTIC ANAEMIA. Dr. Hasan Fahmawi, MRCP(London), FRCP(Edin) Consultant Physician

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

Approach to Hemolysis

Haemolytic anaemias. Dr. J Potgieter Department of Haematology NHLS Tshwane Academic Division

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

Year 2002 Paper two: Questions supplied by Jo 1

The Child with a Hematologic Alteration

Hematologic changes in systemic diseases. Chittima Sirijerachai

Dr. Shiva Nazari Assistant Professor of Pediatric Oncologist & Hematologist Shahid Beheshti Medical Science University Mofid Children s Hospital

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Outline. What is aplastic anemia? 9/19/2012. Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options

2. Non- hemolytic anemias 3. Normocytic Normochromic Normocytic Normochromic Blood loss. (MCV<80 fl) (MCV fl) (MCV>100 fl)

Heme Questions and Derivatives for the USMLE Step One Exam. Winter Storm Skylar Edition

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY HEMOLYTIC ANEMIAS. Dr. Tariq Aladily

Aplastic Anemia Pathophysiology and Approach to Therapy

Aplastic Anemia: Understanding your Disease and Treatment Options

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results

Approach to a pale child

Faculty of Medicine Dr. Tariq Aladily

Updates for your practice August 2013 TLALELETSO. HIV & Anemia. Continued on Page 2

APPROACHING TO PANCYTOPENIA

Immunohematology (Introduction)

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

SESSION 1 Reactive cytopenia and dysplasia

CHERYL KOVALSKI, DO FACOI NO DISCLOSURES ACOI BOARD REVIEW 2018

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

9/23/2018. Investigation of Hemolysis in the Clinical Laboratory. Objectives. What is hemolysis?

SOLIRIS (eculizumab) Slide # 1. How do we treat PNH?

HEMOLYTIC ANEMIA Anemia of increased destruction Normochromic, normochromic anemia Shortened RBC survival Reticulocytosis - Response to increased RBC

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Immunohematology (Introduction) References: -Blood Groups and Red Cell Antigens (Laura Dean) -Cellular and molecular immunology, 8 th edition

Year 2003 Paper two: Questions supplied by Tricia

Diagnostic Approach to Patients with Anemia

HEME 10 Bleeding Disorders

Participants Identification No. % Evaluation. Spherocyte Educational Erythrocyte, normal Educational

Myelodysplastic Syndrome: Let s build a definition

Warm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report

New phase 2 Clinical Trial Enrolling Now

HEMOLY L TIC AN A EMIA

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Index. Note: Page numbers of article titles are in boldface type.

Kingdom of Bahrain Arabian Gulf University College of Medicine and Medical Sciences Hematology

PNH Glossary of Terms

Clinical & Laboratory Assessment

Aplastic anamia & Sideroblastic anemia

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

Pediatric Hematology-Oncology

Approach to Anemia PG CME

Non-immune acquired haemolytic anaemias. Dr.Maysem

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

4 Jumana Jihad Dr. Ahmad Mansour Dr. Ahmad Mansour

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias

MDS: Who gets it and how is it diagnosed?

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

Aplastic Anemia. is a bone marrow failure disease 9/19/2017. What you need to know about. The 4 major components of blood

Introduction and Approach to Anemia

Al-Balqa Applied University Faculty of Medicine

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Peripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY

Hematology Unit Lab 1 Review Material

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

RBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

New phase 2 Clinical Trial Enrolling Now

Thalassemia Maria Luz Uy del Rosario, M.D.

The importance of thrombocytopenia and its causes

PCCN Review Hematology

Diagnosis / Lab Findings

Pediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency.

Dialogue between Clinician and Pathologist on CBC report

Does Morphology Matter in 2017

Pediatrics. Aplastic Anemia in Children Prognosis and Survival Rate. Definition of Aplastic Anemia. See online here

Dana Alsulaibi. - Ahmad Almuhtaseb. - Tariq Al - Adaily

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

There are two main causes of a low platelet count

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD

Hemostatic System - general information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Transcription:

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi

Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH 1400, bilirubin 7mg/dl,d 2.5mg/dl, DAT +3.Bld film spherocytosis, polychromasia. Bld film Supravital stain(retics)

Case 3 CT Abdomen AbdominalUS BM aspirate BM:erythroid hyperplasia with megaloblastoid changes Diagnosis: AIHA. Treated with steroids + folic acid, complete response, but 9 months later had NHL.

Hemolysis= RBC destruction= Shortend RBC Survival with or without anemia Hemolytic Anemias Classification By sites of red cell destruction: intra v extravascular Acquired (immune, Non-immune). v congenital (membrane: HS, Enzymopathies: G6PD def/pk, Hb-pathies: Thal, ss) By mechanism of red cell damage:

Extravascular Hemolysis Ingested by RE cell (spleen & liver) Heme Globin

Hemolysis Evidence for increased red cell production In the blood: Elevated reticulocyte count (corrected/rpi) Circulating NRBCs may be present In the bone marrow: erythroid hyperplasia reduced M/E (myeloid/ erythroid erythroid ratio) In the bone: Deforming changes in the skull and long bones ( frontal bossing )

General Clinical Features 1- Anemia syndrome 2- Splenomegaly 3-gallstones. 4- Dark urine (tea-colored or red) 5- Patients may have chronic ankle ulcers. 6- Aplastic crises associated with Parvovirus B19, may occur 7- Increased requirement for folate

Gallbladder stones/ biliary/ pigment stones

Parvovirus B19 Non-encapsulated DNA virus. Infects and lyses RBC precursors in marrow, causing 7-10d cessation of erythropoiesis. Normal individuals have no significant hematologic effect, since RBCs have normal life span. In pts with hemolytic anemias, loss of red cell production causes Aplastic Crisis

Autoimmune Hemolytic Anemia Warm antibodies (IgG-mediated) Primary 45% Secondary 40% Lymphoproliferative disease Connective tissue disease Infectious disease Drug-induced 15% Laboratory testing Normocytic/macrocytic anemia Peripheral smear - spherocytosis

Anti-Globulin (Coombs) Testing Direct antiglobulin testing(dat) Patients RBCs + Anti-C3d Anti-IgG Indirect antiglobulin testing + + Patients serum RBCs Anti-IgG

Treatment of Autoimmune Hemolytic Anemia (Warm Antibody type) Treat underlying disease if indicated Prednisone (1 mg/kg/day for two weeks, then taper) Splenectomy?? Other Immunosuppressive agents IVIG

Hemolytic Anemia with Intravascular Hemolysis Mechanical damage (Microangiopathic hemolytic anemia) Chemical damage (Burns) Infection (Malaria or Babesiosis) Transfusion reaction (ABO incompatibility)

Differential Diagnosis of Microangiopathic Hemolytic Anemia Thrombotic thrombocytopenic purpura (TTP) Hemolytic uremic syndrome (HUS) Disseminated intravascular coagulation (DIC) Vasculitis Malignant hypertension Metastatic neoplasm with vascular invasion Preeclampsia/HELLP syndrome of pregnancy

Schistocytes: Microangiopathic Hemolytic Anemia

Case 3 B 19 yr old male presented with anemia syndrome, fever and easy bruising. No splenomegaly Hb 6 g/dl,wbc 1500 : N10%, L 80%, others 10%. Retics 0,001%.MCV 105fl,Plt 20k. BM/ Trephine CXR/lobar pneumonia

APLASTIC ANEMIA Aplastic anemia is a severe, life threatening syndrome in which production of erythrocytes, WBCs, and platelets has failed. Aplastic anemia may occur in all age groups and both genders. The disease is characterized by peripheral pancytopenia and accompanied by a hypocellular bone marrow.

APLASTIC ANEMIA Pathophysiology: The primary defect is a reduction in or depletion of hematopoietic precursor stem cells with decreased production of all cell lines This may be due to quantitative or qualitative damage to the pluripotential stem cell. In rare instances it is the result of abnormal hormonal stimulation of stem cell proliferation or the result of a defective bone marrow microenvironment or from cellular or humoral immunosuppression of hematopoiesis.

Causes of Bone Marrow Failure Acquired - Idiopathic - PNH Secondary - Drugs - - radiation - Viruses Inherited - Fanconi anemia - Diamond-Blackfan Anemia - Other rare conditions

Clinical manifestations of AA»Anemia syndrome»neutropenia syndrome»thrombocytopenia syndrome»combination of the above»combination of the above

Presenting Symptoms of Aplastic Anemia. Symptoms Number of Patients Bleeding 41 Anemia 27 Bleeding and anemia 14 Bleeding and infection 6 Infection 5 Routine examination 8 Total 101

Classification of aplastic anemia 1. Severe aplastic anemia is defined if at last two of the following criteria are present: - ANC < 0.5 - PLT < 20 - RTC < 1% Hypoplastic bone marrow (less than 25%) on biopsy 2. Very severe aplastic anemia - criteria as above but ANC < 0.2 3. Non-severe aplastic anemia.

Treatment of AA» Remove causative agent, if known» Supportive care RBC transfusions Treat infections Treat Bleeding» Bone marrow transplant» Immune suppression _ CSA _ ATG Combination of the above

Survival of Patients with AA

RELATED DISORDERS 1- Disorders in which there is peripheral pancytopenia, but the bone marrow is normocellular, hypercellular, or infiltrated with abnormal cellular elements (Myelopthesic anemia) replacement of bone marrow by fibrotic, granulomatous, or neoplastic cells 2- Pure red Cell aplasia 3- Myelodysplastic syndrome (MDS)